Abstract
In the past century, the lifespan of the human population has dramatically increased to the 80 s, but it is hindered by a limited health span to the 60 s due to an epidemic increase in the cardiovascular disease which is a main cause of morbidity and mortality. We cannot underestimate the progress in understanding the major cardiovascular risk factors which include cigarette smoking, dietary, and sedentary lifestyle risks. Despite their clinical significance, these modifiable risk factors are still the major contributors to cardiovascular disease. It is, therefore, important to understand the specific molecular mechanisms behind their pathological effects to develop new therapies to improve the treatment of cardiovascular disease. In recent years, our group and others have made a progress in understanding how these risk factors can promote endothelial dysfunction, smooth muscle dysregulation, vascular inflammation, hypertension, lung, and heart diseases. These factors, despite differences in their nature, lead to stereotypical alterations in vascular metabolism and function. Interestingly, cigarette smoking has a tremendous impact on a very distant site from the initial epithelial exposure, namely circulation and vascular cells mediated by a variety of stable cigarette smoke components which promote vascular oxidative stress and alter vascular metabolism and function. Similarly, dietary and sedentary lifestyle risks facilitate vascular cell metabolic reprogramming promoting vascular oxidative stress and dysfunction. Mitochondria are critical in cellular metabolism, and in this work, we discuss a new concept that mitochondria are a common pathobiological target for these risk factors, and mitochondria-targeted treatments may have a therapeutic effect in the patients with cardiovascular disease.
Similar content being viewed by others
Data availability
Not applicable.
References
(2010) In: How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the surgeon general. Publications and Reports of the Surgeon General. Atlanta (GA)
Agarwal AR, Yin F, Cadenas E (2014) Short-term cigarette smoke exposure leads to metabolic alterations in lung alveolar cells. Am J Respir Cell Mol Biol 51:284–293. https://doi.org/10.1165/rcmb.2013-0523OC
Agarwal AR, Zhao L, Sancheti H, Sundar IK, Rahman I, Cadenas E (2012) Short-term cigarette smoke exposure induces reversible changes in energy metabolism and cellular redox status independent of inflammatory responses in mouse lungs. Am J Physiol Lung Cell Mol Physiol 303:L889-898. https://doi.org/10.1152/ajplung.00219.2012
Ait-Aissa K, Norwood-Toro LE, Terwoord J, Young M, Paniagua LA, Hader SN, Hughes WE, Hockenberry JC, Beare JE, Linn J, Kohmoto T, Kim J, Betts DH, LeBlanc AJ, Gutterman DD, Beyer AM (2022) Noncanonical role of telomerase in regulation of microvascular redox environment with implications for coronary artery disease. Function (Oxf) 3:043. https://doi.org/10.1093/function/zqac043
Amorim JA, Coppotelli G, Rolo AP, Palmeira CM, Ross JM, Sinclair DA (2022) Mitochondrial and metabolic dysfunction in ageing and age-related diseases. Nat Rev Endocrinol 18:243–258. https://doi.org/10.1038/s41574-021-00626-7
Anazawa T, Dimayuga PC, Li H, Tani S, Bradfield J, Chyu KY, Kaul S, Shah PK, Cercek B (2004) Effect of exposure to cigarette smoke on carotid artery intimal thickening: the role of inducible NO synthase. Arterioscler Thromb Vasc Biol 24:1652–1658. https://doi.org/10.1161/01.ATV.0000139925.84444.ad
Audrain-McGovern J, Benowitz NL (2011) Cigarette smoking, nicotine, and body weight. Clin Pharmacol Ther 90:164–168. https://doi.org/10.1038/clpt.2011.105
Azarbal AF, Repella T, Carlson E, Manalo EC, Palanuk B, Vatankhah N, Zientek K, Keene DR, Zhang W, Abraham CZ, Moneta GL, Landry GJ, Alkayed NJ, Sakai LY (2022) A novel model of tobacco smoke-mediated aortic injury. Vasc Endovascular Surg 56:244–252. https://doi.org/10.1177/15385744211063054
Bakker H, Jaddoe VW (2011) Cardiovascular and metabolic influences of fetal smoke exposure. Eur J Epidemiol 26:763–770. https://doi.org/10.1007/s10654-011-9621-2
Balhara YP (2012) Tobacco and metabolic syndrome. Indian J Endocrinol Metab 16:81–87. https://doi.org/10.4103/2230-8210.91197
Barragan R, Ortega-Azorin C, Sorli JV, Asensio EM, Coltell O, St-Onge MP, Portoles O, Corella D (2021) Effect of physical activity, smoking, and sleep on telomere length: a systematic review of observational and intervention studies. J Clin Med 11. https://doi.org/10.3390/jcm11010076
Bauer T, Trump S, Ishaque N, Thurmann L, Gu L, Bauer M, Bieg M, Gu Z, Weichenhan D, Mallm JP, Roder S, Herberth G, Takada E, Mucke O, Winter M, Junge KM, Grutzmann K, Rolle-Kampczyk U, Wang Q, Lawerenz C, Borte M, Polte T, Schlesner M, Schanne M, Wiemann S, Georg C, Stunnenberg HG, Plass C, Rippe K, Mizuguchi J, Herrmann C, Eils R, Lehmann I (2016) Environment-induced epigenetic reprogramming in genomic regulatory elements in smoking mothers and their children. Mol Syst Biol 12:861. https://doi.org/10.15252/msb.20156520
Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, Pletcher MJ, Goldman L (2010) Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med 362:590–599. https://doi.org/10.1056/NEJMoa0907355
Braidy N, Berg J, Clement J, Khorshidi F, Poljak A, Jayasena T, Grant R, Sachdev P (2019) Role of nicotinamide adenine dinucleotide and related precursors as therapeutic targets for age-related degenerative diseases: rationale, biochemistry, pharmacokinetics, and outcomes. Antioxid Redox Signal 30:251–294. https://doi.org/10.1089/ars.2017.7269
Brand MD (2010) The sites and topology of mitochondrial superoxide production. Exp Gerontol 45:466–472. https://doi.org/10.1016/j.exger.2010.01.003
Brautigam L, Jensen LD, Poschmann G, Nystrom S, Bannenberg S, Dreij K, Lepka K, Prozorovski T, Montano SJ, Aktas O, Uhlen P, Stuhler K, Cao Y, Holmgren A, Berndt C (2013) Glutaredoxin regulates vascular development by reversible glutathionylation of sirtuin 1. Proc Natl Acad Sci U S A 110:20057–20062. https://doi.org/10.1073/pnas.1313753110
Brittain EL, Niswender K, Agrawal V, Chen X, Fan R, Pugh ME, Rice TW, Robbins IM, Song H, Thompson C, Ye F, Yu C, Zhu H, West J, Newman JH, Hemnes AR (2020) Mechanistic phase II clinical trial of metformin in pulmonary arterial hypertension. J Am Heart Assoc 9:018349. https://doi.org/10.1161/JAHA.120.018349
Caia GL, Efimova OV, Velayutham M, El-Mahdy MA, Abdelghany TM, Kesselring E, Petryakov S, Sun Z, Samouilov A, Zweier JL (2012) Organ specific mapping of in vivo redox state in control and cigarette smoke-exposed mice using EPR/NMR co-imaging. J Magn Reson 216C:21–27
Caliri AW, Tommasi S, Besaratinia A (2021) Relationships among smoking, oxidative stress, inflammation, macromolecular damage, and cancer. Mutat Res Rev Mutat Res 787:108365. https://doi.org/10.1016/j.mrrev.2021.108365
Centers for Disease Control and Prevention. Hypertension cascade: hypertension prevalence, treatment and control estimates among U.S. adults aged 18 years and older applying the criteria from the American College of Cardiology and American Heart Association’s 2017 Hypertension Guideline—NHANES 2015–2018. Atlanta, GA: U.S. Department of Health and Human Services; 2021. Accessed March 12, 2021
Chalouhi N, Ali MS, Starke RM, Jabbour PM, Tjoumakaris SI, Gonzalez LF, Rosenwasser RH, Koch WJ, Dumont AS (2012) Cigarette smoke and inflammation: role in cerebral aneurysm formation and rupture. Mediators Inflamm 2012:271582. https://doi.org/10.1155/2012/271582
Chen QW, Edvinsson L, Xu CB (2010) Cigarette smoke extract promotes human vascular smooth muscle cell proliferation and survival through ERK1/2- and NF-kappaB-dependent pathways. ScientificWorldJournal 10:2139–2156. https://doi.org/10.1100/tsw.2010.201
Cheskin LJ, Hess JM, Henningfield J, Gorelick DA (2005) Calorie restriction increases cigarette use in adult smokers. Psychopharmacology 179:430–436. https://doi.org/10.1007/s00213-004-2037-x
Chiolero A, Faeh D, Paccaud F, Cornuz J (2008) Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am J Clin Nutr 87:801–809. https://doi.org/10.1093/ajcn/87.4.801
Cornelius ME, Loretan CG, Wang TW, Jamal A, Homa DM (2022) Tobacco product use among adults - United States, 2020. MMWR Morb Mortal Wkly Rep 71:397–405. https://doi.org/10.15585/mmwr.mm7111a1
D’Onofrio N, Vitiello M, Casale R, Servillo L, Giovane A, Balestrieri ML (2015) Sirtuins in vascular diseases: emerging roles and therapeutic potential. Biochim Biophys Acta 1852:1311–1322. https://doi.org/10.1016/j.bbadis.2015.03.001
Dai X, Gakidou E, Lopez AD (2022) Evolution of the global smoking epidemic over the past half century: strengthening the evidence base for policy action. Tob Control 31:129–137. https://doi.org/10.1136/tobaccocontrol-2021-056535
Daiber A, Steven S, Vujacic-Mirski K, Kalinovic S, Oelze M, Di Lisa F, Munzel T (2020) Regulation of vascular function and inflammation via cross talk of reactive oxygen and nitrogen species from mitochondria or NADPH oxidase-implications for diabetes progression. Int J Mol Sci 21. https://doi.org/10.3390/ijms21103405
Davies SD, May-Zhang LS, Boutaud O, Amarnath V, Kirabo A, Harrison DG (2019) Isolevuglandins as mediators of disease and the development of dicarbonyl scavengers as pharmaceutical interventions. Pharmacol Ther 205:107418. https://doi.org/10.1016/j.pharmthera.2019.107418
Deppen SA, Grogan EL, Aldrich MC, Massion PP (2014) Lung cancer screening and smoking cessation: a teachable moment? J Natl Cancer Inst 106:122. https://doi.org/10.1093/jnci/dju122
Dikalov S, Dikalova A (2022) Mitochondrial deacetylase Sirt3 in vascular dysfunction and hypertension. Curr Opin Nephrol Hypertens 31:151–156. https://doi.org/10.1097/MNH.0000000000000771
Dikalov S, Itani HA, Richmond B, Arslanbaeva L, Vergeade A, Rahman SMJ, Boutaud O, Blackwell T, Massion PP, Harrison DG, Dikalova AE (2019) Tobacco smoking induces cardiovascular mitochondrial oxidative stress, promotes endothelial dysfunction and enhances hypertension. Am J Physiol Heart Circ Physiol 316:H639–H646. https://doi.org/10.1152/ajpheart.00595.2018
Dikalov SI, Nazarewicz RR, Bikineyeva A, Hilenski L, Lassegue B, Griendling K, Harrison DG, Dikalova A (2014) Nox2-induced production of mitochondrial superoxide in angiotensin II - mediated endothelial oxidative stress and hypertension. Antioxid Redox Signal 20:281–294. https://doi.org/10.1089/ars.2012.4918
Dikalova AE, Bikineyeva AT, Budzyn K, Nazarewicz RR, McCann L, Lewis W, Harrison DG, Dikalov SI (2010) Therapeutic targeting of mitochondrial superoxide in hypertension. Circ Res 107:106–116
Dikalova AE, Itani HA, Nazarewicz RR, McMaster WG, Fessel JP, Flynn CR, Gamboa JL, Harrison DG, Dikalov SI (2017) Sirt3 impairment and SOD2 hyperacetylation in vascular oxidative stress and hypertension. Circ Res 121:664–774
Dikalova AE, Pandey AK, Xiao L, Arslanbaeva L, Sidorova T, Lopez MG, Billings FTt, Verdin E, Auwerx J, Harrison DG, Dikalov SI, (2020) Mitochondrial deacetylase Sirt3 reduces vascular dysfunction and hypertension while Sirt3 depletion in essential hypertension is linked to vascular inflammation and oxidative stress. Circ Res 126:439–452. https://doi.org/10.1161/CIRCRESAHA.119.315767
Dolinsky VW, Morton JS, Oka T, Robillard-Frayne I, Bagdan M, Lopaschuk GD, Des Rosiers C, Walsh K, Davidge ST, Dyck JR (2010) Calorie restriction prevents hypertension and cardiac hypertrophy in the spontaneously hypertensive rat. Hypertension 56:412–421. https://doi.org/10.1161/HYPERTENSIONAHA.110.154732
Doughan AK, Harrison DG, Dikalov SI (2008) Molecular mechanisms of angiotensin II mediated mitochondrial dysfunction. Linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ Res 102:488–496
Elwing J, Panos RJ (2008) Pulmonary hypertension associated with COPD. Int J Chron Obstruct Pulmon Dis 3:55–70. https://doi.org/10.2147/copd.s1170
Fontana L, Meyer TE, Klein S, Holloszy JO (2004) Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans. Proc Natl Acad Sci U S A 101:6659–6663. https://doi.org/10.1073/pnas.0308291101
Forini F, Canale P, Nicolini G, Iervasi G (2020) Mitochondria-targeted drug delivery in cardiovascular disease: a long road to nano-cardio medicine. Pharmaceutics 12. https://doi.org/10.3390/pharmaceutics12111122
Groppelli A, Giorgi DM, Omboni S, Parati G, Mancia G (1992) Persistent blood pressure increase induced by heavy smoking. J Hypertens 10:495–499
Guarente L (2013) Calorie restriction and sirtuins revisited. Genes Dev 27:2072–2085. https://doi.org/10.1101/gad.227439.113
Heilbronn LK, de Jonge L, Frisard MI, DeLany JP, Larson-Meyer DE, Rood J, Nguyen T, Martin CK, Volaufova J, Most MM, Greenway FL, Smith SR, Deutsch WA, Williamson DA, Ravussin E, Pennington CT (2006) Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: a randomized controlled trial. JAMA 295:1539–1548. https://doi.org/10.1001/jama.295.13.1539
Heydari G, Heidari F, Yousefifard M, Hosseini M (2014) Smoking and diet in healthy adults: a cross-sectional study in tehran, iran, 2010. Iran J Public Health 43:485–491
Hofer SJ, Davinelli S, Bergmann M, Scapagnini G, Madeo F (2021) Caloric restriction mimetics in nutrition and clinical trials. Front Nutr 8:717343. https://doi.org/10.3389/fnut.2021.717343
Ibrahim A, Yucel N, Kim B, Arany Z (2020) Local mitochondrial ATP production regulates endothelial fatty acid uptake and transport. Cell Metab 32(309–319):307. https://doi.org/10.1016/j.cmet.2020.05.018
Jaimes EA, DeMaster EG, Tian RX, Raij L (2004) Stable compounds of cigarette smoke induce endothelial superoxide anion production via NADPH oxidase activation. Arterioscler Thromb Vasc Biol 24:1031–1036. https://doi.org/10.1161/01.ATV.0000127083.88549.58
Javadov S, Kozlov AV, Camara AKS (2020) Mitochondria in health and diseases. Cells 9. https://doi.org/10.3390/cells9051177
Kawachi I, Colditz GA, Stampfer MJ, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH (1994) Smoking cessation and time course of decreased risks of coronary heart disease in middle-aged women. Arch Intern Med 154:169–175
Kim M, Han CH, Lee MY (2014) NADPH oxidase and the cardiovascular toxicity associated with smoking. Toxicol Res 30:149–157. https://doi.org/10.5487/TR.2014.30.3.149
Kirabo A, Fontana V, de Faria AP, Loperena R, Galindo CL, Wu J, Bikineyeva AT, Dikalov S, Xiao L, Chen W, Saleh MA, Trott DW, Itani HA, Vinh A, Amarnath V, Amarnath K, Guzik TJ, Bernstein KE, Shen XZ, Shyr Y, Chen SC, Mernaugh RL, Laffer CL, Elijovich F, Davies SS, Moreno H, Madhur MS, Roberts J 2nd, Harrison DG (2014) DC isoketal-modified proteins activate T cells and promote hypertension. J Clin Invest 124:4642–4656. https://doi.org/10.1172/JCI74084
Kiyooka T, Ohanyan V, Yin L, Pung YF, Chen YR, Chen CL, Kang PT, Hardwick JP, Yun J, Janota D, Peng J, Kolz C, Guarini G, Wilson G, Shokolenko I, Stevens DA, Chilian WM (2022) Mitochondrial DNA integrity and function are critical for endothelium-dependent vasodilation in rats with metabolic syndrome. Basic Res Cardiol 117:3. https://doi.org/10.1007/s00395-021-00908-1
Kume H, Yamada R, Sato Y, Togawa R (2023) Airway smooth muscle regulated by oxidative stress in COPD. Antioxidants (Basel) 12. https://doi.org/10.3390/antiox12010142
Leone A (2011) Does smoking act as a friend or enemy of blood pressure? Let release Pandora’s box. Cardiol Res Pract 2011:264894. https://doi.org/10.4061/2011/264894
Li H, Xia N, Hasselwander S, Daiber A (2019) Resveratrol and vascular function. Int J Mol Sci 20. https://doi.org/10.3390/ijms20092155
Li Y, Yu C, Shen G, Li G, Shen J, Xu Y, Gong J (2015) Sirt3-MnSOD axis represses nicotine-induced mitochondrial oxidative stress and mtDNA damage in osteoblasts. Acta Biochim Biophys Sin (Shanghai) 47:306–312. https://doi.org/10.1093/abbs/gmv013
Li Z, Zhao H, Wang J (2021) Metabolism and chronic inflammation: the links between chronic heart failure and comorbidities. Front Cardiovasc Med 8:650278. https://doi.org/10.3389/fcvm.2021.650278
Lloyd-Jones DM, Allen NB, Anderson CAM, Black T, Brewer LC, Foraker RE, Grandner MA, Lavretsky H, Perak AM, Sharma G, Rosamond W, American Heart A (2022) Life’s essential 8: updating and enhancing the American Heart Association’s Construct of Cardiovascular Health: a presidential advisory from the American Heart Association. Circulation 146:e18–e43. https://doi.org/10.1161/CIR.0000000000001078
Maas SCE, Mens MMJ, Kuhnel B, van Meurs JBJ, Uitterlinden AG, Peters A, Prokisch H, Herder C, Grallert H, Kunze S, Waldenberger M, Kavousi M, Kayser M, Ghanbari M (2020) Smoking-related changes in DNA methylation and gene expression are associated with cardio-metabolic traits. Clin Epigenetics 12:157. https://doi.org/10.1186/s13148-020-00951-0
Madani A, Alack K, Richter MJ, Kruger K (2018) Immune-regulating effects of exercise on cigarette smoke-induced inflammation. J Inflamm Res 11:155–167. https://doi.org/10.2147/JIR.S141149
Metta S, Basalingappa DR, Uppala S, Mitta G (2015) Erythrocyte antioxidant defenses against cigarette smoking in ischemic heart disease. J Clin Diagn Res 9:08–11. https://doi.org/10.7860/JCDR/2015/12237.6128
Michiels C (2003) Endothelial cell functions. J Cell Physiol 196:430–443. https://doi.org/10.1002/jcp.10333
Minami J, Ishimitsu T, Matsuoka H (1999) Effects of smoking cessation on blood pressure and heart rate variability in habitual smokers. Hypertension 33:586–590
Mishra A, Chaturvedi P, Datta S, Sinukumar S, Joshi P, Garg A (2015) Harmful effects of nicotine. Indian J Med Paediatr Oncol 36:24–31. https://doi.org/10.4103/0971-5851.151771
Morrow JD (2005) Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans. Arterioscler Thromb Vasc Biol 25:279–286. https://doi.org/10.1161/01.ATV.0000152605.64964.c0
Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y, Strauss WE, Oates JA, Roberts LJ 2nd (1995) Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med 332:1198–1203. https://doi.org/10.1056/NEJM199505043321804
Nagathihalli NS, Massion PP, Gonzalez AL, Lu P, Datta PK (2012) Smoking induces epithelial-to-mesenchymal transition in non-small cell lung cancer through HDAC-mediated downregulation of E-cadherin. Mol Cancer Ther 11:2362–2372. https://doi.org/10.1158/1535-7163.MCT-12-0107
Ngwenyama N, Kirabo A, Aronovitz M, Velazquez F, Carrillo-Salinas F, Salvador AM, Nevers T, Amarnath V, Tai A, Blanton RM, Harrison DG, Alcaide P (2021) Isolevuglandin-modified cardiac proteins drive CD4+ T-cell activation in the heart and promote cardiac dysfunction. Circulation 143:1242–1255. https://doi.org/10.1161/CIRCULATIONAHA.120.051889
Nisoli E, Tonello C, Cardile A, Cozzi V, Bracale R, Tedesco L, Falcone S, Valerio A, Cantoni O, Clementi E, Moncada S, Carruba MO (2005) Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science 310:314–317. https://doi.org/10.1126/science.1117728
Ostfeld AM (1967) The interaction of biological and social variables in cardiovascular disease. Milbank Mem Fund Q 45(Suppl):13–18
Ozden O, Park SH, Kim HS, Jiang H, Coleman MC, Spitz DR, Gius D (2011) Acetylation of MnSOD directs enzymatic activity responding to cellular nutrient status or oxidative stress. Aging (Albany NY) 3:102–107
Panov AV, Mayorov VI, Dikalova AE, Dikalov SI (2022) Long-chain and medium-chain fatty acids in energy metabolism of murine kidney mitochondria. Int J Mol Sci 24. https://doi.org/10.3390/ijms24010379
Patrick DM, de la Visitacion N, Krishnan J, Chen W, Ormseth MJ, Stein CM, Davies SS, Amarnath V, Crofford LJ, Williams JM, Zhao S, Smart CD, Dikalov S, Dikalova A, Xiao L, Van Beusecum JP, Ao M, Fogo AB, Kirabo A, Harrison DG (2022) Isolevuglandins disrupt PU.1-mediated C1q expression and promote autoimmunity and hypertension in systemic lupus erythematosus. JCI Insight 7. https://doi.org/10.1172/jci.insight.136678
Peluffo G, Calcerrada P, Piacenza L, Pizzano N, Radi R (2009) Superoxide-mediated inactivation of nitric oxide and peroxynitrite formation by tobacco smoke in vascular endothelium: studies in cultured cells and smokers. Am J Physiol Heart Circ Physiol 296:H1781-1792. https://doi.org/10.1152/ajpheart.00930.2008
Pillai VB, Sundaresan NR, Jeevanandam V, Gupta MP (2010) Mitochondrial SIRT3 and heart disease. Cardiovasc Res 88:250–256. https://doi.org/10.1093/cvr/cvq250
Prasad S, Sajja RK, Kaisar MA, Park JH, Villalba H, Liles T, Abbruscato T, Cucullo L (2017) Role of Nrf2 and protective effects of Metformin against tobacco smoke-induced cerebrovascular toxicity. Redox Biol 12:58–69. https://doi.org/10.1016/j.redox.2017.02.007
Qiu X, Brown K, Hirschey MD, Verdin E, Chen D (2010) Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab 12:662–667. https://doi.org/10.1016/j.cmet.2010.11.015
Quitting Smoking Among Adults - United States - (2011) Weekly. 60(44); 1513–1519: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6044a6042.htm#tab6041
Raffin J, de Souto Barreto P, Le Traon AP, Vellas B, Aubertin-Leheudre M, Rolland Y (2023) Sedentary behavior and the biological hallmarks of aging. Ageing Res Rev 83:101807. https://doi.org/10.1016/j.arr.2022.101807
Rahman MM, Laher I (2007) Structural and functional alteration of blood vessels caused by cigarette smoking: an overview of molecular mechanisms. Curr Vasc Pharmacol 5:276–292
Rahman SM, Ji X, Zimmerman LJ, Li M, Harris BK, Hoeksema MD, Trenary IA, Zou Y, Qian J, Slebos RJ, Beane J, Spira A, Shyr Y, Eisenberg R, Liebler DC, Young JD, Massion PP (2016) The airway epithelium undergoes metabolic reprogramming in individuals at high risk for lung cancer. JCI insight 1:88814. https://doi.org/10.1172/jci.insight.88814
Raza H, John A, Nemmar A (2013) Short-term effects of nose-only cigarette smoke exposure on glutathione redox homeostasis, cytochrome P450 1A1/2 and respiratory enzyme activities in mice tissues. Cell Physiol Biochem 31:683–692. https://doi.org/10.1159/000350087
Rossman MJ, Santos-Parker JR, Steward CAC, Bispham NZ, Cuevas LM, Rosenberg HL, Woodward KA, Chonchol M, Gioscia-Ryan RA, Murphy MP, Seals DR (2018) Chronic supplementation with a mitochondrial antioxidant (MitoQ) improves vascular function in healthy older adults. Hypertension 71:1056–1063. https://doi.org/10.1161/HYPERTENSIONAHA.117.10787
Roth GA, Johnson C, Abajobir A et al (2017) Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol 70:1–25. https://doi.org/10.1016/j.jacc.2017.04.052
Rotllan N, Camacho M, Tondo M, Diarte-Anazco EMG, Canyelles M, Mendez-Lara KA, Benitez S, Alonso N, Mauricio D, Escola-Gil JC, Blanco-Vaca F, Julve J (2021) Therapeutic potential of emerging NAD+-increasing strategies for cardiovascular diseases. Antioxidants (Basel) 10. https://doi.org/10.3390/antiox10121939
Sacco RL, Benjamin EJ, Broderick JP, Dyken M, Easton JD, Feinberg WM, Goldstein LB, Gorelick PB, Howard G, Kittner SJ, Manolio TA, Whisnant JP, Wolf PA (1997) American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors Stroke 28:1507–1517
Sacks FM, Lichtenstein AH, Wu JHY, Appel LJ, Creager MA, Kris-Etherton PM, Miller M, Rimm EB, Rudel LL, Robinson JG, Stone NJ, Van Horn LV, American Heart A (2017) Dietary fats and cardiovascular disease: a presidential advisory from the American Heart Association. Circulation 136:e1–e23. https://doi.org/10.1161/CIR.0000000000000510
Sasaki J, Iwashita M, Kono S (2006) Statins: beneficial or adverse for glucose metabolism. J Atheroscler Thromb 13:123–129. https://doi.org/10.5551/jat.13.123
Sevilla-Montero J, Labrousse-Arias D, Fernandez-Perez C, Fernandez-Blanco L, Barreira B, Mondejar-Parreno G, Alfaro-Arnedo E, Lopez IP, Perez-Rial S, Peces-Barba G, Pichel JG, Peinado VI, Cogolludo A, Calzada MJ (2021) Cigarette smoke directly promotes pulmonary arterial remodeling and Kv7.4 channel dysfunction. Am J Respir Crit Care Med 203:1290–1305. https://doi.org/10.1164/rccm.201911-2238OC
Sevilla-Montero J, Munar-Rubert O, Pino-Fadon J, Aguilar-Latorre C, Villegas-Esguevillas M, Climent B, Agro M, Choya-Foces C, Martinez-Ruiz A, Balsa E, Munoz-Calleja C, Gomez-Punter RM, Vazquez-Espinosa E, Cogolludo A, Calzada MJ (2022) Cigarette smoke induces pulmonary arterial dysfunction through an imbalance in the redox status of the soluble guanylyl cyclase. Free Radic Biol Med 193:9–22. https://doi.org/10.1016/j.freeradbiomed.2022.09.026
Shimosato T, Geddawy A, Tawa M, Imamura T, Okamura T (2012) Chronic administration of nicotine-free cigarette smoke extract impaired endothelium-dependent vascular relaxation in rats via increased vascular oxidative stress. J Pharmacol Sci 118:206–214
Starke RM, Ali MS, Jabbour PM, Tjoumakaris SI, Gonzalez F, Hasan DM, Rosenwasser RH, Owens GK, Koch WJ, Dumont AS (2013) Cigarette smoke modulates vascular smooth muscle phenotype: implications for carotid and cerebrovascular disease. PLoS One 8:71954. https://doi.org/10.1371/journal.pone.0071954
Stewart J, Manmathan G, Wilkinson P (2017) Primary prevention of cardiovascular disease: a review of contemporary guidance and literature. JRSM Cardiovasc Dis 6:2048004016687211. https://doi.org/10.1177/2048004016687211
Tao R, Vassilopoulos A, Parisiadou L, Yan Y, Gius D (2014) Regulation of MnSOD enzymatic activity by Sirt3 connects the mitochondrial acetylome signaling networks to aging and carcinogenesis. Antioxid Redox Signal 20:1646–1654. https://doi.org/10.1089/ars.2013.5482
Tian R, Colucci WS, Arany Z, Bachschmid MM, Ballinger SW, Boudina S, Bruce JE, Busija DW, Dikalov S, Dorn GW II, Galis ZS, Gottlieb RA, Kelly DP, Kitsis RN, Kohr MJ, Levy D, Lewandowski ED, McClung JM, Mochly-Rosen D, O’Brien KD, O’Rourke B, Park JY, Ping P, Sack MN, Sheu SS, Shi Y, Shiva S, Wallace DC, Weiss RG, Vernon HJ, Wong R, Schwartz Longacre L (2019) Unlocking the secrets of mitochondria in the cardiovascular system: path to a cure in heart failure-a report from the 2018 National Heart, Lung, and Blood Institute Workshop. Circulation 140:1205–1216. https://doi.org/10.1161/CIRCULATIONAHA.119.040551
Townsend N, Kazakiewicz D, Lucy Wright F, Timmis A, Huculeci R, Torbica A, Gale CP, Achenbach S, Weidinger F, Vardas P (2022) Epidemiology of cardiovascular disease in Europe. Nat Rev Cardiol 19:133–143. https://doi.org/10.1038/s41569-021-00607-3
Triggle CR, Samuel SM, Ravishankar S, Marei I, Arunachalam G, Ding H (2012) The endothelium: influencing vascular smooth muscle in many ways. Can J Physiol Pharmacol 90:713–738. https://doi.org/10.1139/y2012-073
Tsuchiya M, Asada A, Kasahara E, Sato EF, Shindo M, Inoue M (2002) Smoking a single cigarette rapidly reduces combined concentrations of nitrate and nitrite and concentrations of antioxidants in plasma. Circulation 105:1155–1157
Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA (2022) The global burden of cardiovascular diseases and risk: a compass for future health. J Am Coll Cardiol 80:2361–2371. https://doi.org/10.1016/j.jacc.2022.11.005
Wang J, Wang L, Chen X, Liang ML, Wei DH, Cao W, Zhang J (2022) Cigarette smoke extract stimulates human pulmonary artery smooth muscle cell proliferation: role of inflammation and oxidative stress. Iran J Basic Med Sci 25:755–761. https://doi.org/10.22038/IJBMS.2022.64170.14133
Wang W, Zhao T, Geng K, Yuan G, Chen Y, Xu Y (2021) Smoking and the pathophysiology of peripheral artery disease. Front Cardiovasc Med 8:704106. https://doi.org/10.3389/fcvm.2021.704106
Whitehead AK, Erwin AP, Yue X (2021) Nicotine and vascular dysfunction. Acta Physiol (Oxf) 231:13631. https://doi.org/10.1111/apha.13631
World Health Organization. International Agency for Research on Cancer. Reversal of risk after quitting smoking. Risk of cardiovascular diseases after smoking cessation. (2007). IARC Handbook of Cancer Prevention vol 11
Wu J, Saleh MA, Kirabo A, Itani HA, Montaniel KR, Xiao L, Chen W, Mernaugh RL, Cai H, Bernstein KE, Goronzy JJ, Weyand CM, Curci JA, Barbaro NR, Moreno H, Davies SS, Roberts LJ 2nd, Madhur MS, Harrison DG (2016) Immune activation caused by vascular oxidation promotes fibrosis and hypertension. J Clin Invest 126:50–67. https://doi.org/10.1172/JCI80761
Xing AP, Du YC, Hu XY, Xu JY, Zhang HP, Li Y, Nie X (2012) Cigarette smoke extract stimulates rat pulmonary artery smooth muscle cell proliferation via PKC-PDGFB signaling. J Biomed Biotechnol 2012:534384. https://doi.org/10.1155/2012/534384
Xiong J, Kawagishi H, Yan Y, Liu J, Wells QS, Edmunds LR, Fergusson MM, Yu ZX, Rovira II, Brittain EL, Wolfgang MJ, Jurczak MJ, Fessel JP, Finkel T (2018) A metabolic basis for endothelial-to-mesenchymal transition. Mol Cell 69(689–698):687. https://doi.org/10.1016/j.molcel.2018.01.010
Yu W, Qin J, Chen C, Fu Y, Wang W (2018) Moderate calorie restriction attenuates ageassociated alterations and improves cardiac function by increasing SIRT1 and SIRT3 expression. Mol Med Rep 18:4087–4094. https://doi.org/10.3892/mmr.2018.9390
Yu Y, Zhou L, Yang Y, Liu Y (2018) Cycloastragenol: an exciting novel candidate for age-associated diseases. Exp Ther Med 16:2175–2182. https://doi.org/10.3892/etm.2018.6501
Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, Brauer M, Kutty VR, Gupta R, Wielgosz A, AlHabib KF, Dans A, Lopez-Jaramillo P, Avezum A, Lanas F, Oguz A, Kruger IM, Diaz R, Yusoff K, Mony P, Chifamba J, Yeates K, Kelishadi R, Yusufali A, Khatib R, Rahman O, Zatonska K, Iqbal R, Wei L, Bo H, Rosengren A, Kaur M, Mohan V, Lear SA, Teo KK, Leong D, O’Donnell M, McKee M, Dagenais G (2020) Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet 395:795–808. https://doi.org/10.1016/S0140-6736(19)32008-2
Zhu Y, Park SH, Ozden O, Kim HS, Jiang H, Vassilopoulos A, Spitz DR, Gius D (2012) Exploring the electrostatic repulsion model in the role of Sirt3 in directing MnSOD acetylation status and enzymatic activity. Free Radic Biol Med 53:828–833. https://doi.org/10.1016/j.freeradbiomed.2012.06.020
Funding
This work was supported by funding from the National Institutes of Health (R01HL144943 and RO1HL157583) and the American Heart Association Transformational Project Award (19TPA34910157).
Ethics declarations
Ethics approval and consent to participate
Not applicable.
Human and animal ethics
Not applicable.
Consent for publication
Authors give consent for the publication of identifiable details, which can include images and details within the text (“Material”) to be published in the above journal and article.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is published as part of the Special Issue on “Impact of lifestyle and behavioral risk factors on endothelial function and vascular biology.”
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Dikalov, S.I., Gutor, S. & Dikalova, A.E. Pathological mechanisms of cigarette smoking, dietary, and sedentary lifestyle risks in vascular dysfunction: mitochondria as a common target of risk factors. Pflugers Arch - Eur J Physiol 475, 857–866 (2023). https://doi.org/10.1007/s00424-023-02806-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00424-023-02806-y